Laurent Levy, Nanobiotix 🇫🇷 | Nanoparticles, Radiotherapy | E45

As Philip travels to France, Nanobiotix CEO Laurent Lévy discusses how the company broke into Europe’s exclusive $1 billion biotech club, alongside the likes of Abivax and Medincell. They also chat about what it means to partner with giants like Johnson & Johnson, and how Laurent’s leadership style has evolved over his long tenure.
⭐️ ABOUT THE SPEAKERLaurent Lévy co-founded Nanobiotics in 2003 and has served as CEO ever since. Before this, he worked in a variety of roles with companies including Altran Technologies, Valbiotis and Sanofi.He has a doctorate in nanomaterials-focused physical chemistry from the Pierre and Marie Curie University in Paris.
🔗 LINKS MENTIONED
• Nanobiotix website -- nanobiotix.com
• Nanobiotix's $71 million deal with Healthcare Royalty -- ir.nanobiotix.com/news-releases/news-release-d…
• Nanobiotix's first phase 1 data -- ir.nanobiotix.com/news-releases/news-release-d…

📜 TRANSCRIPT
Read the full transcript here: flot.bio/episode/laurent-levy-nanobiotix-nanop…
💸 DONATEWe welcome donations from individuals and businesses to support our podcast and allow us to create even more content: paypal.me/PhilipHemme
⭐️ SPONSORSHIP
Ready to amplify your brand to influential leaders in biotech and biopharma? Contact nick@flot.bio and unlock sponsorship opportunities in our podcasts!
🫶 FOLLOW US
• Newsletter: eepurl.com/h_fnmH
• LinkedIn: linkedin.com/company/flot-bio
• X (Twitter): x.com/FlotBio

🙏 LIKE/FOLLOW/REVIEW
Did you enjoy the episode? Please hit the like and subscribe button. Also, please let me know your thoughts in the comments below.
🎙️ ABOUT FLOT.BIO
Flot.bio is a show to watch the best Europeans in biotech to help you grow. Hosted by Philip Hemme. 25k monthly views. Free.
⏰ TIMESTAMPS
• [00:00:00] Intro
• [00:02:11] Soaring stocks with clinical results
• [00:04:08] Nanobiotix's history
• [00:07:39] Nanoparticles and radiotherapy
• [00:13:42] Developing NBTXR3
• [00:25:02] Universal cancer radiotherapy enhancers
• [00:28:28] Few competitors
• [00:33:37] Biotech in France, Europe and the US
• [00:37:19] Laurent Lévy’s leadership style
• [00:42:16] Quick-fire questions